These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38705152)

  • 1. Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study.
    Attia A; Webb J; Connor K; Johnston CJC; Williams M; Gordon-Walker T; Rowe IA; Harrison EM; Stutchfield BM
    Lancet Healthy Longev; 2024 May; 5(5):e346-e355. PubMed ID: 38705152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant benefit-based offering of deceased donor livers in the United Kingdom.
    Allen E; Taylor R; Gimson A; Thorburn D
    J Hepatol; 2024 Sep; 81(3):471-478. PubMed ID: 38521169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list.
    Magder LS; Regev A; Mindikoglu AL
    Transpl Int; 2012 Apr; 25(4):409-15. PubMed ID: 22299756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Donor and Recipient Age With Preoperative MELD and UKELD Scores for Predicting Survival After Liver Transplantation.
    Kostakis ID; Iype S; Nasralla D; Davidson BR; Imber C; Sharma D; Pollok JM
    Exp Clin Transplant; 2021 Jun; 19(6):570-579. PubMed ID: 34085606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    Saldaña RS; Schrem H; Barthold M; Kaltenborn A
    PLoS One; 2017; 12(1):e0170499. PubMed ID: 28129338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
    Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
    PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation.
    Ow MM; Erasmus P; Minto G; Struthers R; Joseph M; Smith A; Warshow UM; Cramp ME; Cross TJ
    Liver Transpl; 2014 Sep; 20(9):1081-8. PubMed ID: 24805969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
    J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.
    Malik AK; Masson S; Allen E; Akyol M; Bathgate A; Davies M; Hidalgo E; Hudson M; Powell J; Taylor R; Zarankaite A; Manas DM;
    Transplantation; 2019 Nov; 103(11):2304-2311. PubMed ID: 30830042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Among Different Domains of Quality Among US Liver Transplant Programs.
    Brown CS; Waits SA; Englesbe MJ; Sonnenday CJ; Sheetz KH
    JAMA Netw Open; 2021 Aug; 4(8):e2118502. PubMed ID: 34369991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
    Rodríguez-Perálvarez ML; Gómez-Orellana AM; Majumdar A; Bailey M; McCaughan GW; Gow P; Guerrero M; Taylor R; Guijo-Rubio D; Hervás-Martínez C; Tsochatzis EA
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.